Growth Metrics

Omnicell (OMCL) EBIAT (2016 - 2026)

Omnicell has reported EBIAT over the past 16 years, most recently at -$2.0 million for Q4 2025.

  • Quarterly EBIAT fell 112.79% to -$2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2025, down 83.62% year-over-year, with the annual reading at $2.1 million for FY2025, 83.62% down from the prior year.
  • EBIAT was -$2.0 million for Q4 2025 at Omnicell, down from $5.5 million in the prior quarter.
  • Over five years, EBIAT peaked at $29.3 million in Q3 2021 and troughed at -$28.4 million in Q4 2022.
  • The 5-year median for EBIAT is $5.6 million (2023), against an average of $3.9 million.
  • Year-over-year, EBIAT soared 575.09% in 2021 and then tumbled 303.19% in 2022.
  • A 5-year view of EBIAT shows it stood at $14.0 million in 2021, then tumbled by 303.19% to -$28.4 million in 2022, then surged by 49.4% to -$14.4 million in 2023, then skyrocketed by 210.21% to $15.8 million in 2024, then tumbled by 112.79% to -$2.0 million in 2025.
  • Per Business Quant, the three most recent readings for OMCL's EBIAT are -$2.0 million (Q4 2025), $5.5 million (Q3 2025), and $5.6 million (Q2 2025).